Order Article Reprints

Szanto CL, Cornel AM, Tamminga SM, Delemarre EM, de Koning CCH, van den Beemt DAMH, Dunnebach E, Tas ML, Dierselhuis MP, Tytgat LGAM, et al. Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma. Cancers. 2021; 13(9):2096. https://doi.org/10.3390/cancers13092096

Szanto, Celina L., Annelisa M. Cornel, Sara M. Tamminga, Eveline M. Delemarre, Coco C. H. de Koning, Denise A. M. H. van den Beemt, Ester Dunnebach, Michelle L. Tas, Miranda P. Dierselhuis, Lieve G. A. M. Tytgat, and et al. 2021. "Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma" Cancers 13, no. 9: 2096. https://doi.org/10.3390/cancers13092096

Szanto, C. L., Cornel, A. M., Tamminga, S. M., Delemarre, E. M., de Koning, C. C. H., van den Beemt, D. A. M. H., Dunnebach, E., Tas, M. L., Dierselhuis, M. P., Tytgat, L. G. A. M., van Noesel, M. M., Kraal, K. C. J. M., Boelens, J.-J., Huitema, A. D. R., & Nierkens, S. (2021). Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma. Cancers, 13(9), 2096. https://doi.org/10.3390/cancers13092096